Skip to main content
. Author manuscript; available in PMC: 2017 Jan 17.
Published in final edited form as: Exp Neurol. 2016 Jun 15;283(Pt A):151–156. doi: 10.1016/j.expneurol.2016.06.015

Fig. 2.

Fig. 2

tat-M2NX does not protect TRPM2−/− mice following 60 min tMCAO. Quantification of percentage of infarct volume from WT and TRPM2−/− mice brains stained with TTC. TRPM2−/− male mice were treated with 20 mg/kg tat-M2NX peptide or vehicle.